Society of Interventional Oncology

End the year on the right foot by reading this top #IO article from 2024, published by The ASCO Post. Learn how the addition of durvalumab and bevacizumab to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable hepatocellular carcinoma who were eligible for embolization. According to the study authors, this is the first trial to demonstrate improved clinical outcomes for immunotherapy-based combinations with TACE in these patients. Read more: https://lnkd.in/gcDKnnJn

Calling all SIO members! 📣 Don't forget that the deadline to renew your membership is 31 December. Make sure to renew your SIO membership before the year ends and set yourself up for success and professional growth in 2025 and beyond. Renew before it's too late: https://bit.ly/3GdS4WF

Exciting news! We are proud to share that SIO was honored last month with the 2024 Pierre Award at the annual RevUP Summit, hosted by the Professionals for Association Revenue (PAR). The award was accepted by SIO's executive director, Jena Stack, M.Ed, PMP. This prestigious recognition celebrates SIO’s groundbreaking fundraising achievement for the ACCLAIM Trial — the first multi-industry supported international clinical trial in interventional radiology, advancing microwave ablation as a treatment for colorectal liver metastases. A huge "thank you" from our entire SIO team and Board of Directors for this achievement, and to our industry supporters, Varian, NeuWave (Johnson & Johnson MedTech) and Boston Scientific who made this possible for the #IO specialty! Read the full press release: https://lnkd.in/g9vbhqqG

As in years past, SIO is proud to host several multidisciplinary tumor boards at our Annual Scientific Meeting — the premier event for interventional oncology (#IO). Wondering what to expect? We tell you here! 👇 - Engage with cutting-edge research - Participate in expert-led discussions - Advance your skills and elevate your practice These highly anticipated sessions are a must for every #IO professional! Register now before rates increase on 1 January: https://bit.ly/3Bne9mA

Next on the list of our top #IO articles from 2024, check out this ScienceDirect article that overviews how SIRT is a promising endovascular treatment for hepatocellular carcinoma, recommended for early- and intermediate-stage HCC and advanced-stage HCC without extrahepatic metastasis. Understanding prognostic factors and optimizing technical procedures can enhance outcomes across various clinical scenarios. Read more: https://lnkd.in/gGix59Cq

Planning to attend #SIOVegas? Add the Head, Neck, and Thyroid Ablation Master Class to your registration, taking place on 30 January 2025! Here's a look at the topics we will cover in session two: - Pros and Cons of Ablation for Low-Grade Thyroid Lesions: Fourat Ridouani, MD, Memorial Sloan Kettering Cancer Center - Post-Ablation or Post-Surgical Thyroid Cancer Recurrence: Giovanni Mauri, MD, IRCCS Ospedale Galeazzi - Sant'Ambrogio - Embolization of Goiter and Thyroid Cancer: Alan Alper Sag, MD, University of Miami Miller School of Medicine - Complications and How to Mitigate Them: Timothy Huber, MD, MD Anderson Cancer Center - Practice & Business Development: Alexander Lam, MD, University of California, San Francisco Register now: https://lnkd.in/d2J_eu-P

Don’t let your SIO benefits lapse! As 2024 winds down, now is the time to secure your place in the elite SIO community for 2025.💡Stay ahead in the field of interventional oncology (#IO) with exclusive resources, connections, and tools designed to keep you at the top of your profession. Renew by 31 December to maintain uninterrupted access: https://bit.ly/3GdS4WF

Dive into the origins and unique aspects of the Society of Interventional Oncology in the latest episode of the IO Learning Podcast. Join Muneeb Ahmed, MD, FSIR, Michael Soulen, MD, and AJ Gunn, MD, FSIR, as they discuss the founding of SIO, how it fits alongside other radiology societies, and what sets the SIO Annual Meeting (#SIOVegas) apart. Don’t miss this insightful conversation with leading experts! Tune in now: https://lnkd.in/gj4_vVgp

We're counting down to the new year by featuring the top #IO articles from 2024. Check out this study published in Frontiers in Immunology via National Center for Biotechnology Information (NCBI) Intermediate-stage (BCLC-B) hepatocellular carcinoma (HCC) beyond the up-to-11 criteria presents a significant therapeutic challenge, with a high and heterogeneous tumor burden. This study evaluates the effectiveness and safety of transarterial chemoembolization (TACE) combined with lenvatinib and tislelizumab for patients facing these challenges. Read more to get the latest insights, background, methods, and results: https://lnkd.in/gqAAKG2d

Join us on Saturday, 1 February 2025, in Las Vegas for the Breast Cryoablation Mini Master Class, part of the SIO Annual Scientific Meeting. Here's a sneak peek of session two 👀: - Fundamentals of Pre-ablation Imaging, Lesion Selection, and Patient Work-up: Eric de Kerviler, MD, Saint-Louis Hospital - Breast Cancer Cryoablation: Step-by-step: Orsi Franco, MD European Institute of Oncology - Post-ablation Imaging: Algorithm and Imaging Findings: Monica L. Huang, MD, FACR, MD Anderson Cancer Center Don’t miss this opportunity to advance your expertise in cutting-edge care. Learn more and register now: https://bit.ly/47sAriD #SIOVegas #BreastCryo